Drug checking in Switzerland

TL;DR

• Anonymous, free or low-cost (0–20 CHF), legally protected.
• Zurich: DIBS (Kanonengasse) — mobile testing at events.
• Bern: CheckYourDrugs (Contact Netz).
• Geneva: Nuit Blanche? (Première Ligne). Basel: DIZ.

What gets tested — and what doesn't

• THC and CBD content (quantitative, HPLC).
• Synthetic cannabinoids (K2/Spice) — most common contaminant in 'CBD flower' 2023–24.
• Pesticides and heavy metals: only at full labs (not mobile units).
• Microbiology (mold): usually not standard, on request.

Analytical depth and the identification of contaminants

Laboratory analysis within the scope of drug checking is not limited to determining the main active ingredients. Modern analytical methods make it possible to precisely identify unwanted cutting agents and toxic additives. This is particularly important for cannabis products, as visually inconspicuous flowers can be sprayed with synthetic cannabinoids. These artificial substances bind far more strongly to receptors in the brain than natural THC and pose unpredictable health risks. Systematic testing exposes the discrepancy between declared and actual quality.

In addition to synthetic active ingredients, cultivation residues such as pesticides, fertilizers, or heavy metals can also endanger consumers' health. While simple rapid tests for home use are often unreliable and do not provide exact quantitative data, stationary services offer reliable substance identification. The data obtained is integrated in anonymized form into cantonal and national monitoring systems. This allows authorities to react early to contaminated batches or new, potentially dangerous substances on the black market and to publish targeted warnings.

• Precise identification of highly potent synthetic cannabinoids
• Differentiation between natural ingredients and artificial cutting agents
• Detection of health-hazardous residues from uncontrolled cultivation
• Contribution to the national early warning system for health protection

Legal anchoring and cantonal practice in Switzerland

In Switzerland, harm reduction is firmly anchored as one of the four pillars of the national drug policy. The Federal Office of Public Health supports these measures to minimize the health risks of consumption. Although the possession of cannabis with a total THC content of over one percent is fundamentally illegal, testing centers operate within a legally protected framework. In practice, handing over a micro-quantity for analysis is not considered punishable acquisition or possession in terms of promoting narcotics consumption, provided it takes place within the framework of state-recognized drug checking.

However, the concrete implementation and financing of these services are regulated at the cantonal level, leading to regional differences in availability. While urban centers have established stationary counseling centers, consumers in rural regions often have to rely on mobile services at events. The police generally tolerate travel to the testing center, but there is no absolute legal guarantee against a personal search on the way there. If an amount of less than ten grams of THC cannabis is carried during a check, this can be punished with a fixed penalty of one hundred francs for adults.

• Anchoring of drug checking in the federal harm reduction pillar
• Cantonal responsibility for the financing and provision of services
• Legal gray area on the transport route to the drop-off point
• Fixed penalty fine regulation for carrying less than ten grams of THC cannabis

The consultation as a harm reduction tool

A central component of Swiss drug checking is the mandatory link between sample submission and a personal consultation. The analysis is not understood merely as a quality control service, but as an entry point into a dialogue about consumption patterns. Professionals use this contact to provide objective information about the risks of consumption without moralizing. In doing so, individual consumption habits are reflected upon and harm-reducing behaviors are conveyed. This also reaches individuals who are otherwise not addressed by traditional addiction support services.

During the consultation, consumers are sensitized to the dangers of mixed consumption, particularly in combination with alcohol or other substances. The psychological aspects of cannabis use, such as the risk of triggering latent psychosis or anxiety states, are also addressed. Feedback on the laboratory results is usually provided a few days later by telephone or in person, which offers another opportunity to evaluate consumption behavior in light of the actual active ingredient concentration. This promotes personal responsibility and protects against accidental overdoses caused by unexpectedly highly potent flowers.

• Combination of chemical analysis and psychosocial counseling
• Conveying harm-reducing rules of conduct
• Raising awareness of the dangers of mixed consumption and psychological side effects
• Reflection on one's own consumption when the laboratory values are disclosed

FAQ